Article 28 May 2024 2024 Guide To The IRA And Other Drug Pricing Initiatives: Impact On Life Sciences Investments United States Healthcare
Article 09 May 2024 FDA Finalizes LDT Regulation, With Significant Exceptions: Enforcement Of Requirements Will Phase In Over Four Years United States Healthcare
Article 01 May 2024 The Regulatory Race Is On: The Biden Administration Sprints To Issue Key Health Policies United States Healthcare
Article 16 Apr 2024 2024 Guide To DOJ And HHS OIG Guidance On Effective Compliance Programs United States Healthcare
Article 05 Mar 2024 Cannabis In 2024: HHS Rescheduling Recommendation And SAFER Banking United States Cannabis
Article 03 Jan 2024 FDA Serves Up More Food For Thought: 2024 Will Be A Pivotal Year For The Agency's Reorganization Efforts United States Healthcare
Article 04 Oct 2023 FDA's Proposed Rule On Laboratory Developed Tests: One Small Change To Regulatory Language That Would Mark A Giant Leap In Lab Testing Regulation United States Healthcare
Article 13 Jul 2023 From Private Equity Ownership To PBMs And Drug Pricing: Congress Scrutinizes The Health Care Industry United States Healthcare
Article 18 Apr 2023 FDA Gets Digital, Agency Issues Digital Health Policies On PCCP, Cybersecurity And Drug Development United States Healthcare